JapanStake
Pharmaceutical · Fiscal year end Dec 31

CHUGAI PHARMACEUTICAL CO., LTD.

4519

中外製薬株式会社

FIGI BBG000BJVLC14519.T4519 JPCorp. no. 5011501002900

Latest half-year results

First half · fiscal year to 2026-12 · filed 2026-07-27

For the first half of the fiscal year to 2026-12: Revenue ¥663.3 billion (+14.7% YoY), Profit before tax ¥329.2 billion (+21.1% YoY), Net income ¥231.7 billion (+19.2% YoY).

This periodYear on year
Revenue¥663.3bn+14.7%
Profit before tax¥329.2bn+21.1%
Net profit to owners¥231.7bn+19.2%

From the securities report on EDINET, which states no forecast. History via /v1/companies/4519/earnings-releases.

Financials

IFRS · consolidated · fiscal year to 2025-12-31
Revenue
¥1.3tn
Net income
¥434.0bn
ROE
22.1%
Equity ratio
82.1%
Dividend / share
¥272
Employees
7,872
Revenue · ¥tn
FY2021: ¥1.0tn 1 FY2021FY2022: ¥1.3tn 1.26 FY2022FY2023: ¥1.1tn 1.11 FY2023FY2024: ¥1.2tn 1.17 FY2024FY2025: ¥1.3tn 1.26 FY2025
Net income · ¥bn
FY2021: ¥303.0bn 303 FY2021FY2022: ¥374.4bn 374 FY2022FY2023: ¥325.5bn 325 FY2023FY2024: ¥387.3bn 387 FY2024FY2025: ¥434.0bn 434 FY2025
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2025-12-31¥1,257.9bn¥434.0bn¥2,468.6bn¥2,025.7bn22.1%¥263.73¥386.3bn
2024-12-31¥1,170.6bn¥387.3bn¥2,208.4bn¥1,901.5bn22.0%¥235.39¥447.6bn
2023-12-31¥1,111.4bn¥325.5bn¥1,932.5bn¥1,625.6bn21.3%¥197.83¥409.9bn
2022-12-31¥1,259.7bn¥374.4bn¥1,869.8bn¥1,424.4bn28.7%¥227.64¥243.6bn
2021-12-31¥999.8bn¥303.0bn¥1,538.7bn¥1,188.0bn28.0%¥184.29¥279.6bn

Indicators

Computed by us from filings · fiscal year to 2025-12-31
MetricValuePercentile among listed companies
ROE, %22.190.3
Ordinary margin0.475299.3
Equity ratio, %82.191.9
Revenue growth0.074661.1
Net income growth0.120648.5
Operating cash flow / assets0.156590.8
Policy-uncertainty measure0.00 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 0.1% held by other listed companies.

Results wording balance: +1.00. Proprietary text method; it describes the wording only and does not interpret context.

Via /v1/companies/4519/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Internal control, 2026-03-25: see filing 上記の評価の結果、当事業年度末日時点において、当社グループの財務報告に係る内部統制は有効であると判断いたしました。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Latest voting result: 2026-03-26 · Proposal · passed. /v1/companies/4519/voting

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
— issues
Book value
—
Sold in the year
— — issues
Bought in the year
— — issues
Mutual, both reports
0
Held by listed cos.
6

Held by: Tokio Marine Holdings, Inc. 8766, Sompo Holdings, Inc. 8630, TECHNO RYOWA LTD. 1965, VITAL KSK HOLDINGS,INC. 3151, Toyo Seikan Group Holdings, Ltd. 5901, ASAHI PRINTING CO.,LTD. 3951

Purposes, all holdings and mutual flags via /v1/companies/4519/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2025-12-31
ShareholderSharesRatio
ROCHE HOLDING LTD1,005,670,00061.10%
日本マスタートラスト信託銀行株式会社（信託口）141,887,0008.62%
株式会社日本カストディ銀行（信託口）58,185,0003.53%
STATE STREET BANK AND TRUSTCOMPANY 50500122,990,0001.39%
THE CHASE MANHATTAN BANK, N.A. LONDON SECS LENDING OMNIBUS ACCOUNT21,987,0001.33%
JP MORGAN CHASE BANK 38586412,191,0000.74%
SMBC日興証券株式会社11,197,0000.68%
JP MORGAN CHASE BANK 3857819,479,0000.57%
住友生命保険相互会社9,150,0000.55%
individual holder7,499,0000.45%

U.S. funds holding 4519

SEC Form N-PORT, reports to 2026-07-31

354 U.S. funds held 102,758,941 shares worth $4.62bn.

FundSharesValue% of fundAs of
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND
VANGUARD STAR FUNDS
9,425,150$409.0m0.063%2026-07-31
VANGUARD HEALTH CARE FUND
VANGUARD SPECIALIZED FUNDS
8,264,744$358.6m0.939%2026-07-31
VANGUARD DEVELOPED MARKETS INDEX FUND
VANGUARD TAX-MANAGED FUNDS
6,265,252$289.4m0.091%2026-06-30
EUPAC Fund
EUPAC Fund
6,088,900$281.9m0.200%2026-06-30
iShares Core MSCI EAFE ETF
iShares Trust
4,969,000$215.6m0.113%2026-07-31

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/4519
GET /v1/companies/4519/financials
GET /v1/companies/4519/details
GET /v1/companies/4519/segments
GET /v1/companies/4519/voting
GET /v1/companies/4519/tender-offers
GET /v1/companies/4519/indicators
GET /v1/companies/4519/earnings-releases
GET /v1/events?ticker=4519
GET /v1/companies/4519/trades         
GET /v1/companies/4519/cross-holdings 
GET /v1/companies/4519/brief

Plans from $9 a month · Documentation